Root Cause Analysis Investigation Report. The Royal National Orthopaedic Hospital

Similar documents
Root Cause Analysis Investigation Report. Clostridium Difficile Ian Monro Ward. The Royal National Orthopaedic Hospital

Checklists for Preventing and Controlling

Infection Control Care Plan. Patient Demographic / label. Hospital: Ward:

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

Guideline for the Management of Patients with Known or Suspected Diarrhoea / Viral Gastroenteritis

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13

Clostridium difficile Infection (CDI) Trigger Tool

Includes GP flow chart & out of hours protocols. Page 1 of 11

Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative

This paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST).

Easy read information for patients and visitors. What is clostridium difficile? Clostridium difficile is a germ.

Protocol for the Prevention and Management of Clostridium difficile.

Clostridium difficile policy

Clostridium difficile (C. diff)

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012

Commissioning for Quality & Innovation (CQUIN)

Infection Prevention and Control Annual Report 2015/16

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014

Policy for Control of Diarrhoea and Vomiting due to Norovirus. Vickie Longstaff (Infection Control Nurse Consultant) Version 5

HSE West, Mid-Western Regional Hospitals, Limerick, Guidelines for The Management of Clostridium Difficile, MGIP&C 09/10, Revision 02, 09/12 pg 1 of

Clostridium difficile

Investigating Clostridium difficile Infections

Frequently Asked Questions. (Version # 3-November 2014)

Outbreak Management 2015

Infection Prevention and Control Annual Report 2012/13

General Practice Template. Guidelines for the Management of cases & outbreaks of Norovirus

Management of Patients with Diarrhoea

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery

New document. Reviewed document

CDI case checklist and standard assessment tool. Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE

Quality in patient-centred care planning: nursing interventions to alleviate constipation

Open and Honest Care in your Local Hospital

Developed in response to: Best Practice Infection Prevention and Control

TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS

Influence of Patient Flow on Quality Care

CLOSTRIDIUM DIFFICILE INFECTION PREVENTION AND CONTROL POLICY

HCAI Local implementation team action plan

CoG (04/17) Item 19. Council of Governors. Item for Information. C difficile Action Plan. To note the report. DATE 11 April 2017 REPORT FOR SUBJECT

Guidelines for the Management of C. difficile Infections in. Healthcare Settings. Saskatchewan Infection Prevention and Control Program November 2015

Infection Prevention. & Control. Report

Enhanced Surveillance of Clostridium difficile Infection in Ireland

Enhanced recovery after bowel surgery

CLOSTRIDIUM DIFFICILE ACTION PLAN

PATIENTS WITH DIARRHOEA

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

PROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS

Clostridium difficile

Influence of Patient Flow on Quality Care

CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective

CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT

Open and Honest Care in your Local Hospital

Reducing the risk of healthcare associated infection

Outbreak Management Policy

A Patient s Guide to Distal Femoral Replacement

Definitions. Healthcare Acquired Infection (HCAI)

TRUST BOARD SAFETY AND QUALITY MONTHLY REPORT SEPTEMBER 2013

Enhanced Recovery Programme

MRSA: National developments, Progress, Challenges and Targets

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

Open and Honest Care in your Local Hospital

The School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT

PROTOCOL FOR THE ADMINISTRATION OF SENNA. Formulary and Prescribing Guidelines

Isolation Care of Patients in Isolation due to Infection or Disease

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Management of Clostridium difficile Infection (CDI)

Infection Prevention and Control Outbreak Policy

TRUST BOARD. Date of Meeting: 05/10/2010

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London

Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA

REPORT SUMMARY SHEET

Provincial Surveillance

Decreasing Nosocomial C. diff

Infection Prevention and Control. Clostridium difficile Policy

Clostridium difficile Infection (CDI)

Open and Honest Care in your local Trust

Reducing the risk of healthcare associated infection

Admission Avoidance. Scenario 1 Urinary Tract Infection

National Patient Safety Agency Root Cause Analysis (RCA) Investigation

Announced Inspection Report

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT

Clostridium Difficile Information for patients, staff and relatives

Clostridium difficile Infection (CDI)

Parent/Carer Information Leaflet

Gastroenteritis Policy (Diarrhoea and Vomiting)

Patient Information Leaflet

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards

Pancreaticoduodenectomy enhanced recovery programme (PD ERP) Information for patients

Quality Assurance Framework

Unannounced Theatre Inspection Report

Infection Control Performance Improvement Quality Assurance & Performance Improvement (QAPI) Case Study

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

Infection Prevention & Control Annual Report 2011/2012

POLICY FOR TAKING BLOOD CULTURES

Percutaneous Transhepatic Cholangiogram (PTC) and Biliary Stent

FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION

DRIVING IMPROVEMENT THROUGH INDEPENDENT AND OBJECTIVE REVIEW. Cwm Taf Health Board. Unannounced Cleanliness Spot Check

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital

Enhanced Recovery Programme Major gynaecology surgery

Tenckhoff Catheter Insertion

Transcription:

Root Cause Analysis Investigation Report The Royal National Orthopaedic Hospital Root Cause Analysis on a case of Clostridium Difficile on Margaret Harte March 2012 CONTENTS Incident description and consequences Pre-investigation risk assessment Background and context Terms of reference The investigation team Scope and level of investigation Investigation type, process and methods used Involvement and support of patient and relatives Involvement and support provided for staff involved Information and evidence gathered Chronology of events Detection of incident Notable practice Care and service delivery problems Contributory factors Root causes Lessons learned Recommendations Arrangements for shared learning Distribution list Appendices MAIN REPORT Incident description and consequences This 77 year old lady was admitted to the Royal National Orthopaedic Hospital (RNOH) Margaret Harte Ward on the 30 th March 2012 under the care of Mr Carrington for Left Total knee Replacement. Patient s past medical history is as follows: Right Achilles Tendon repair 1963 Elbow repair 2003 Right knee Arthroscopy 2008 Tibialis Posterior reconstruction + Calcaneal Osteotomy left foot 2009 Bilateral Grade 2 Tibialis posterior dysfunction The patient confirmed that she had no recent history of admission into another hospital and had not been treated with antibiotics prior to this admission into RNOH which was on the 30 th March

2012. At RNOH patient was sent to theatre on the 30/03/2012. 30.03.12: It is document that the patient had last opened her bowels on the 30.03.12 30.03.12: returned to the ward at approx 19.00hrs. PCA in-situ + Fluids 31.03.12: No documentation of bowel movement (AM shift) 31.03.12 (PM shift) Patient complained of feeling nauseated 4mg IV Ondanseton given, bowel not opened, patient drinking well, fluids discontinued. 01.04.12 No documentation of bowel movement (am shift) 01.04.12 Patient passing urine on urge, no bowel movement (pm shift) 02.04.12 13.40hrs Patient complained of nausea and pain plus poor appetite 16.00hrs Food chart commenced, bowel not opened. 03.04.12 04.45hrs Bowels opened x 2, second episode documented that stools were loose. 07.30hrs Handed-over to day shift that the patient had opened her bowels twice over-night, not diarrhoea or offensive. 10.15hrs it was discussed with the patient discharge plan for the following day 18.30hrs Documented that patient has continued poor appetite, dislikes hospital food and will eat better once home. Complained of nausea, laxatives declined, bowels opened twice. 04.04.12: 04.40hrs Offensive diarrhoea x 3 over night, specimen taken by night-staff, site manager informed, barrier nursing commenced. 09.00hrs Infection Control nurse was informed that the patient has ongoing diarrhoea, advised that the patient to be moved into a side-room, If one not available to contact Angus McKinnon Ward (AMU) where a side room maybe available. Type 7 loose stools Stool chart commenced by am shift, patient was barrier nursed at bed-space curtains closed, trolley with gloves, apron and clinical waste bags within bed-space as was commode. Patient informed named staff nurse that she would not be staying in hospital or transferring to another ward or into a side room and that she would be going home today as arranged. It was explained to the patient that it would be better for her to remain in hospital so that her condition can be monitored, as results of the stool sample would take 24 hours. Patient was adamant that she would be going home and if needed would self-discharge. SHO was informed of the situation, who said that he would come and discuss the situation with the patient. 10.30hrs Patient had contacted a member of her family and stated that she would now remain in hospital. Side-room would not be available on AMU until late afternoon. Contact Infection control nurse to ask if it would be ok to transfer that patient into the side-room on MHW and move patient onto the ward. Matron in attendance who also spoke to the patient and the SHO who had just arrived on the ward, 11.45hrs SHO said that he was happy for patient to be discharged home with a course of Metronidazole,

patient happy to do this. 14.30hrs Patient collected and discharged home. 16.00hrs phone call received from Microbiologist at Royal Free Hospital Dr Tan re: stool results, C-Diff positive patient will require 10-14 day course of Metronidazole, Dr Tan is happy for Team to call patient at home and if there are any further problems to contact Dr Tan on the mobile. 16.10hrs Infection control nurse informed of stool result and said that the patient will need to be contacted at home with result and that if she becomes unwell to contact her GP. 16.20hrs Rang patient at home informed her of results, she said that she feels well but has had two episodes of diarrhoea since returning home, advice given. 05.04.12 15.00hrs Infection control nurse rang and spoke to patient s GP informing them C-Diff result and arranged for patient to be reviewed by GP. Antibiotic Treatment: 30.04.12 IV Cefuroxine 1.5mg in theatre (stat dose) 30.04.12 IV Cefuroxine 750mg @ 22.00hrs on the ward 31.04.12 IV Cefuroxine 750mg @ 06.00hrs on the ward 04.04.12 PO Metronidazole 400mg @ 13.00hrs on the ward Patient discharged home with 5 day course of Metronidazole, Microbiologist Dr Tan recommended 10-14 day course. Incident date: 03.04.12 Incident type: Specialty: Clinical Margaret Harte Ward Effect on patient: Distress. Patient was more concerned that she may have to remain in hospital and was adamant that she would be going home as planned. Severity level: Pre-investigation risk assessment A Potential Severity (1-5) B Likelihood of recurrence at that severity (1-5) 2 3 7 C Risk Rating (C = A x B) Background and context Terms of reference This investigation was undertaken using the Root Cause Analysis (RCA) toolkit. The toolkit provided a framework to ensure that relevant facts and information were collected. The purpose of the investigation is not to apportion blame, but to reflect on this case to establish if there

was anything which the organisation could have done to have prevented this case of Clostridium difficile. The findings of this RCA will be shared as appropriate. The investigation team Anna Churchman Tissue Viability Nurse Habibat Olowolusi Ward Sister Margaret Harte Ward Scope and level of investigation A comprehensive investigation was undertaken by the investigation team employed by the Royal National Orthopaedic Hospital. This investigation and the results will be shared with the Infection Control Committee, Clinical Governance Committee, Clinical Risk Outcome Panel and the Clinical Quality Review meeting held by commissioners. Investigation type, process and methods used The investigation team meet up twice to review the medical notes and to discuss the case. Involvement and support of patient and relatives The patient was seen by Matron and SHO and contacted at home post discharge. GP was informed. Involvement and support provided for staff involved The matron and senior sisters will feedback the findings of the RCA locally to all staff, and any training required will be addressed by the Infection Control team. Information and evidence gathered The patient s medical and nursing notes were used in this investigation. Chronology of events At RNOH, the patient was admitted to Margaret Harte Ward on the 30.03.12, was sent to theatre on the same day and was transferred back to the ward after surgery. It is documented that the patient last opened her bowels on the 30.03.12. 31.03.12 no documentation of bowel movement (am shift) 31.03.12 Patient complained of feeling nauseated 4mg Ondanseton given, bowels not opened with (pm shelf). 01.04.12 No documentation of bowel movement. 02.04.12 Patient complained of nausea, pain and poor appetite, bowels not opened Patient refused Senna but did take 15mls of Lactulose at 22.00hrs. Food chart was commenced. 03.04.12 Patient had opened her bowels x 2 over night, second episode was documented that the stools were loose, handed over to day-shift that it was not diarrhoea or offensive. 04.04.12 Offensive diarrhoea x 3 over-night, specimen taken by night staff, site manger informed, barrier nursing commenced. 04.04.12 Infection Control Nurse informed by day shift that patient has on-going diarrhoea, advised to move patient into a side room if available. Stool chart commenced by day shift, patient barrier nursed at bed-space curtains closed, all equipment required kept within bed-space. Patient adamant that she would not be transferring to another ward or into a side-room and would be

going home as discussed. SHO was informed of the situation. SHO was happy for patient to be discharged home with a course of Metronidazole. Patient was collected and discharged home at 14.30hrs Phone call received from Dr Tan Microbiologist at Royal Free Hospital at 16.00hrs that stool sample sent is positive C-Diff and that patient will require 10-14 day course of Metronidazole. Infection Control Nurse informed of result, patient will need to contact their GP if patient becomes unwell. Contacted patient at home informed her of the results, she said that she feels well but has had two episodes of diarrhoea since being discharged, advice given. 05.04.12 Infection Control Nurse contacted patient s GP informing them of the result and arranged for patient to be reviewed by GP. Detection of incident 04.04.12 16.00hrs Stool sample result were Clostridium difficile positive (CDI) Notable practice 1. As soon as it was evident that the patient had diarrhoea, staff on Margaret Harte Ward commenced barrier nursing. 2. A stool sample was collected and sent to Microbiology on 04.04.12 at 9.00hrs both routine and C.difficile tests requested 3. Specimen taken by night-staff, site manager informed and barrier nursing at bed-space commenced. 4. Infection Control Nurse informed, advised to move patient into side-room if available or to contact Angus McKinnon ward where a side-room maybe available. 5. Both Matron and SHO spoke to the patient, as patient was adamant that she would not be remaining in hospital or transferring to another ward. 6. Infection Control precautions adhered to. Care and service delivery problems There is no entry in the patient s case notes to indicate why the antibiotics were given. Furthermore, there is no documentation to indicate that the Microbiologist was consulted for specialist advice and recommendations on the safe use of antibiotics on the affected patient. There is a need for the Trust to form an Antibiotic Steering Group in order to facilitate compliance with antimicrobials policy and guidance. Stool chart not commenced until the second day of reported loose stools. Contributory factors Antibiotic Treatment: 30.04.12 IV Cefuroxine 1.5mg in theatre (stat dose) 30.04.12 IV Cefuroxine 750mg @ 22.00hrs on the ward 31.04.12 IV Cefuroxine 750mg @ 06.00hrs on the ward

04.04.12 PO Metronidazole 400mg @ 13.00hrs on the ward Patient discharged home with 5 day course of Metronidazole, Microbiologist Dr Tan recommended 10-14 day course. Age of Patient (77 years old) Root causes 1. Use of broad spectrum antibiotics Lessons learned 1. Isolation of patients immediately after two episodes of diarrhoea and ensuring that they remain in isolation until 48 hours after passing normal stool. 2. Continued vigilant awareness of the risks associated with antibiotic therapy. 3. Education and training on the use of Bristol stool chart Recommendations 1. In order to maintain C.difficile awareness, the medical & nursing staff need to continue with vigilance and awareness of Clostridium difficile risks as well as prudent antimicrobials stewardship. Arrangements for shared learning This report will be reviewed and an action plan implemented and monitored by the Clinical Governance Committee. Distribution list Infection Control Committee Clinical Governance Committee Trust Board Appendices Appendix 1 Action Plan Author Anna Churchman Job title Tissue Viability Nurse Date 06.06.12

Appendix 2 Clostridium Difficile on Margaret Harte Ward ROOT CAUSE ANALYSIS ACTION PLAN Risk Description Prudent use of antibiotimicrob ials as stipulated in the national guidance and legislation and policies. Controls Currently In Place For each control state whether it is: effective satisfactory uncertain, some weaknesses weak Antimicrobials Policy Royal Free Hospital Infection Services Consequenc e (C ) 1 Insignificant 2 Minor 3 Moderate 4 Major 5 Catastrophic Likelihoo d (L) 1 Rare 2 Unlikely 3 Possible 4 Likely 5 Almost Certain Risk Rating (C X L) 3 4 High Action Description Nursing staff must seek advice from the Infection Control Nurse regarding patient isolation during working hours ( 8.30-16.300). If assistance is needed after hours, Consultant Microbiologist must be contacted. Promote antimicrobials stewardship Start Date Aug 2011 Jan 2012 Anticipated Date Of Completion Aug 2011 Designated Lead Infection Control Pharmacy/ Microbiolog y/icn Risk Rating after actions complete ( C X L including score) 3x 4 = 12 Progress Action Taken For each action state whether it is: Completed Ongoing Ongoing Medical staff to continue seeking Microbiology advice and to review antibiotics vigilantly 3 4 High Medical staff to attend MDT meetings on Spinal Injuries Unit on Tuesdays at 12pm. Aug 2011 Medical Directors 3x 4 = 12 Ongoing